Novo Nordisk (NYSE: NVO)
Novo Nordisk Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novo Nordisk Company Info
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
News & Analysis
4 of the Most Undervalued Stocks in the Market Right Now
They all offer great value right now.
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade
These two underappreciated dividend payers offer above-average yields and relatively rapid payout growth.
Why Novo Nordisk Stock Flew Higher on Friday
It looked good next to a company that has been stealing its thunder lately.
Novo Nordisk Stock Investors Need to Know This
The company is using litigation to protect sales of its most popular treatments.
Novo Nordisk Is Down 70%: Is the Price Too Low To Ignore?
Investors shouldn't expect a V-shaped recovery.
Why Novo Nordisk Stock Slipped Today
The Danish pharmaceutical company is fighting a competitive war on several fronts.
Why Is Everyone Talking About Novo Nordisk Stock?
Competition is hurting sales of critical products.
Why Novo Nordisk Stock Is Down Again Today
Are you brave enough to catch this falling knife?
Valuation
Earnings Transcripts
Novo Nordisk (NVO) Q4 2024 Earnings Call Transcript
NVO earnings call for the period ending December 31, 2024.
Novo Nordisk (NVO) Q3 2024 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2024.
Novo Nordisk (NVO) Q2 2024 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2024.
Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.